It is clear that diabetes has strong implications for cardiovascular morbidity and
mortality, although an increasing number of studies have suggested that fasting plasma
glucose (FPG) values below the diabetes (and prediabetes) threshold also contribute
to increased cardiovascular risk. A body of evidence exists supporting the idea that
FPG values even lower than 100 mg/dL are associated with an increased risk of cardiovascular
morbidity and mortality, after accounting for other variables.
Keywords
To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to European Journal of Internal MedicineAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Assessment and treatment of cardiovascular risk in prediabetes: impaired glucose tolerance and impaired fasting glucose.Am J Cardiol. 2011; 108: 3B-24B
- Expert committee on the diagnosis and classification of diabetes mellitus 2, the expert committee on the diagnosis and classification of diabetes mellitus. Follow-up report on the diagnosis of diabetes mellitus.Diabetes Care. 2003; 26: 3160-3167
- Normal fasting plasma glucose and risk of type 2 diabetes diagnosis.Am J Med. 2008; 121: 519-524
- Impaired fasting glucose: how low should it go?.Diabetes Care. 2000; 23: 34-39
- Fasting glucose levels within the high normal range predict cardiovascular outcome.Am Heart J. 2012; 164: 111-116
- Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk.Ann Intern Med. 2004; 141: 413-420
- Hemoglobin a 1c in nondiabetic patients: an independent predictor of coronary artery disease and its severity.Mayo Clin Proc. 2014; 89: 908-916
- Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study.Arch Intern Med. 2005; 165: 1910-1916
- HbA1c increase is associated with higher coronary and peripheral atherosclerotic burden in non diabetic patients.Atherosclerosis. 2016; 255: 102-108
Article info
Publication history
Published online: May 14, 2018
Accepted:
May 9,
2018
Received:
May 7,
2018
Identification
Copyright
© 2018 European Federation of Internal Medicine. Published by Elsevier B.V. All rights reserved.
